Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1998-11-13
2000-02-01
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514572, 558392, 558393, A61K 31275
Patent
active
060203722
ABSTRACT:
The compound of the formula I or II ##STR1## is suitable for the production of a pharmaceutical for the treatment of carcinomatous disorders, where R.sup.1 is (C.sub.3 -C.sub.5)-cycloalkyl, (C.sub.2 -C.sub.6)-alkenyl or (C.sub.2 -C.sub.6)-alkynyl, R.sup.2 is CF.sub.3, OCF.sub.3, SCF.sub.3, OH, NO.sub.2, halogen, benzyl, phenyl, CN or O-phenyl, R.sup.3 is (C.sub.1 -C.sub.4)-alkyl, halogen or a hydrogen atom and X is a --CH group or a nitrogen atom.
REFERENCES:
patent: 4061767 (1977-12-01), Ertel et al.
patent: 5476866 (1995-12-01), Kuo et al.
patent: 5494911 (1996-02-01), Bartlett et al.
S. Chen et al., Cancer Research, vol. 52, pp. 3521-3527 (1992).
R. Hay et al., American Type Culture Collection Catalogue of Cell Lines and Hybridomas, Sixth Ed. (1988), pp. 168,157,120,126,127.
G. J. Peters et al., Biochemical Pharmacology, vol. 39, No. 1, pp. 135-144 (1990).
G. Schwartsmann et al., Biochemical Pharmacology, vol. 37, No. 1, pp. 3257-3266 (1988).
G.J. Peters et al., Invest. New Drugs, vol. 5, pp. 235-244 (1987).
G.J. Peters et al., Proceedings of AACR, vol. 27, pp. 350, 1392 (Mar., 1988).
R. A. Williamson et al., J. of Biological Chemistry, vol. 270, No. 88, pp. 22467-22472 (Sep. 22, 1995).
Boslett Klaus
Czech Jorg
Schwab Wilfried
Hoechst Aktiengesellschaft
O'Sullivan Peter
LandOfFree
Use of isoxazole and crotonamide derivatives for the treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of isoxazole and crotonamide derivatives for the treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoxazole and crotonamide derivatives for the treatment o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-938008